APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Urine Drug Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Urine Drug Testing Service Market Outlook and Growth Opportunities 2026

Report ID 174263200415 April 2026Not stated

Choose your research edition.

Industry ResearchUrine Drug Testing Service Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Urine Drug Testing Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Urine Drug Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urine Drug Testing Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Urine Drug Testing Service Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Urine Drug Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Urine Drug Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Urine Drug Testing Service market include Abbott, Labcorp, Quest Diagnostics, Millennium Health, Genesis Reference Labs, Concentra, DISA, Medigold Health and Keystone Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Urine Drug Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Urine Drug Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Urine Drug Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Urine Drug Testing Service market.

Urine Drug Testing Service Segment by Company

Abbott

Labcorp

Quest Diagnostics

Millennium Health

Genesis Reference Labs

Concentra

DISA

Medigold Health

Keystone Laboratories

Crystal Health

MedTox

Australian Clinical Labs

Dominion Diagnostics

Matrix Diagnostics

Dorevitch Pathology

Urine Drug Testing Service Segment by Type

On-site Testing

Laboratory-based Testing

Urine Drug Testing Service Segment by Application

Hospital

Clinic

Others

Urine Drug Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Urine Drug Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Urine Drug Testing Service key companies, revenue, market share, and recent developments.

3. To split the Urine Drug Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Urine Drug Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Urine Drug Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Urine Drug Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urine Drug Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urine Drug Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urine Drug Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Urine Drug Testing Service industry.

Chapter 3: Detailed analysis of Urine Drug Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Urine Drug Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Urine Drug Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Urine Drug Testing Service Industry Trends Table 2. Urine Drug Testing Service Industry Drivers Table 3. Urine Drug Testing Service Industry Opportunities and Challenges Table 4. Urine Drug Testing Service Industry Restraints Table 5. Global Urine Drug Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Urine Drug Testing Service Revenue Share by Company (2021-2026) Table 7. Global Urine Drug Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Urine Drug Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global Urine Drug Testing Service Company, Product Type & Application Table 10. Global Urine Drug Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Urine Drug Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-site Testing Table 15. Significant Companies of Laboratory-based Testing Table 16. Global Urine Drug Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Urine Drug Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Urine Drug Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Urine Drug Testing Service Sales Value Share by Type (2021-2026) Table 20. Global Urine Drug Testing Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Others Table 24. Global Urine Drug Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Urine Drug Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Urine Drug Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Urine Drug Testing Service Sales Value Share by Application (2021-2026) Table 28. Global Urine Drug Testing Service Sales Value Share by Application (2027-2032) Table 29. Global Urine Drug Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Urine Drug Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Urine Drug Testing Service Sales Value Share by Region (2021-2026) Table 32. Global Urine Drug Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Urine Drug Testing Service Sales Value Share by Region (2027-2032) Table 34. Global Urine Drug Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Urine Drug Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Urine Drug Testing Service Sales Value Market Share by Country (2021-2026) Table 37. Global Urine Drug Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Urine Drug Testing Service Sales Value Market Share by Country (2027-2032) Table 39. Abbott Company Information Table 40. Abbott Business Overview Table 41. Abbott Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Abbott Urine Drug Testing Service Product Portfolio Table 43. Abbott Recent Development Table 44. Labcorp Company Information Table 45. Labcorp Business Overview Table 46. Labcorp Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Labcorp Urine Drug Testing Service Product Portfolio Table 48. Labcorp Recent Development Table 49. Quest Diagnostics Company Information Table 50. Quest Diagnostics Business Overview Table 51. Quest Diagnostics Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Quest Diagnostics Urine Drug Testing Service Product Portfolio Table 53. Quest Diagnostics Recent Development Table 54. Millennium Health Company Information Table 55. Millennium Health Business Overview Table 56. Millennium Health Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Millennium Health Urine Drug Testing Service Product Portfolio Table 58. Millennium Health Recent Development Table 59. Genesis Reference Labs Company Information Table 60. Genesis Reference Labs Business Overview Table 61. Genesis Reference Labs Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Genesis Reference Labs Urine Drug Testing Service Product Portfolio Table 63. Genesis Reference Labs Recent Development Table 64. Concentra Company Information Table 65. Concentra Business Overview Table 66. Concentra Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Concentra Urine Drug Testing Service Product Portfolio Table 68. Concentra Recent Development Table 69. DISA Company Information Table 70. DISA Business Overview Table 71. DISA Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. DISA Urine Drug Testing Service Product Portfolio Table 73. DISA Recent Development Table 74. Medigold Health Company Information Table 75. Medigold Health Business Overview Table 76. Medigold Health Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Medigold Health Urine Drug Testing Service Product Portfolio Table 78. Medigold Health Recent Development Table 79. Keystone Laboratories Company Information Table 80. Keystone Laboratories Business Overview Table 81. Keystone Laboratories Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Keystone Laboratories Urine Drug Testing Service Product Portfolio Table 83. Keystone Laboratories Recent Development Table 84. Crystal Health Company Information Table 85. Crystal Health Business Overview Table 86. Crystal Health Urine Drug Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Crystal Health Urine Drug Testing Service Product Portfolio Table 88. Crystal Health Recent Development Table 89. MedTox Company Information Table 90. MedTox Business Overview Table 91. MedTox Urine Drug Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. MedTox Urine Drug Testing Service Product Portfolio Table 93. MedTox Recent Development Table 94. Australian Clinical Labs Company Information Table 95. Australian Clinical Labs Business Overview Table 96. Australian Clinical Labs Urine Drug Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Australian Clinical Labs Urine Drug Testing Service Product Portfolio Table 98. Australian Clinical Labs Recent Development Table 99. Dominion Diagnostics Company Information Table 100. Dominion Diagnostics Business Overview Table 101. Dominion Diagnostics Urine Drug Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Dominion Diagnostics Urine Drug Testing Service Product Portfolio Table 103. Dominion Diagnostics Recent Development Table 104. Matrix Diagnostics Company Information Table 105. Matrix Diagnostics Business Overview Table 106. Matrix Diagnostics Urine Drug Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Matrix Diagnostics Urine Drug Testing Service Product Portfolio Table 108. Matrix Diagnostics Recent Development Table 109. Dorevitch Pathology Company Information Table 110. Dorevitch Pathology Business Overview Table 111. Dorevitch Pathology Urine Drug Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Dorevitch Pathology Urine Drug Testing Service Product Portfolio Table 113. Dorevitch Pathology Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Urine Drug Testing Service Product Image Figure 2. Global Urine Drug Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urine Drug Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Urine Drug Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-site Testing Image Figure 8. Laboratory-based Testing Image Figure 9. Global Urine Drug Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Urine Drug Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Urine Drug Testing Service Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Urine Drug Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Urine Drug Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Urine Drug Testing Service Sales Value Share by Application (2021-2032) Figure 18. Global Urine Drug Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Urine Drug Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Urine Drug Testing Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Urine Drug Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Urine Drug Testing Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Urine Drug Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Urine Drug Testing Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Urine Drug Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Urine Drug Testing Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Urine Drug Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Urine Drug Testing Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Urine Drug Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Urine Drug Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • On-site Testing
  • Laboratory-based Testing
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Labcorp
  • Quest Diagnostics
  • Millennium Health
  • Genesis Reference Labs
  • Concentra
  • DISA
  • Medigold Health
  • Keystone Laboratories
  • Crystal Health
  • MedTox
  • Australian Clinical Labs
  • Dominion Diagnostics
  • Matrix Diagnostics
  • Dorevitch Pathology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Urine Drug Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Urine Drug Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Urine Drug Testing Service Market Dynamics
  1. 2.1 Urine Drug Testing Service Industry Trends
  2. 2.2 Urine Drug Testing Service Industry Drivers
  3. 2.3 Urine Drug Testing Service Industry Opportunities and Challenges
  4. 2.4 Urine Drug Testing Service Industry Restraints
3 Urine Drug Testing Service Market by Company
  1. 3.1 Global Urine Drug Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global Urine Drug Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global Urine Drug Testing Service Company Ranking (2024-2026)
  4. 3.4 Global Urine Drug Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Urine Drug Testing Service Company Product Type and Application
  6. 3.6 Global Urine Drug Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Urine Drug Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Urine Drug Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Urine Drug Testing Service Market by Type
  1. 4.1 Urine Drug Testing Service Type Introduction
  2. 4.1.1 On-site Testing
  3. 4.1.2 Laboratory-based Testing
  4. 4.2 Global Urine Drug Testing Service Sales Value by Type
  5. 4.2.1 Global Urine Drug Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Urine Drug Testing Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Urine Drug Testing Service Sales Value Share by Type (2021-2032)
5 Urine Drug Testing Service Market by Application
  1. 5.1 Urine Drug Testing Service Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Urine Drug Testing Service Sales Value by Application
  6. 5.2.1 Global Urine Drug Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Urine Drug Testing Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Urine Drug Testing Service Sales Value Share by Application (2021-2032)
6 Urine Drug Testing Service Regional Value Analysis
  1. 6.1 Global Urine Drug Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Urine Drug Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Urine Drug Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Urine Drug Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Urine Drug Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America Urine Drug Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Urine Drug Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Urine Drug Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Urine Drug Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Urine Drug Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Urine Drug Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America Urine Drug Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Urine Drug Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Urine Drug Testing Service Sales Value Share by Country, 2025 VS 2032
7 Urine Drug Testing Service Country-level Value Analysis
  1. 7.1 Global Urine Drug Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Urine Drug Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Urine Drug Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Urine Drug Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Urine Drug Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Urine Drug Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Urine Drug Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Urine Drug Testing Service Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Labcorp
  8. 8.2.1 Labcorp Company Information
  9. 8.2.2 Labcorp Business Overview
  10. 8.2.3 Labcorp Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Labcorp Urine Drug Testing Service Product Portfolio
  12. 8.2.5 Labcorp Recent Developments
  13. 8.3 Quest Diagnostics
  14. 8.3.1 Quest Diagnostics Company Information
  15. 8.3.2 Quest Diagnostics Business Overview
  16. 8.3.3 Quest Diagnostics Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Quest Diagnostics Urine Drug Testing Service Product Portfolio
  18. 8.3.5 Quest Diagnostics Recent Developments
  19. 8.4 Millennium Health
  20. 8.4.1 Millennium Health Company Information
  21. 8.4.2 Millennium Health Business Overview
  22. 8.4.3 Millennium Health Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Millennium Health Urine Drug Testing Service Product Portfolio
  24. 8.4.5 Millennium Health Recent Developments
  25. 8.5 Genesis Reference Labs
  26. 8.5.1 Genesis Reference Labs Company Information
  27. 8.5.2 Genesis Reference Labs Business Overview
  28. 8.5.3 Genesis Reference Labs Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Genesis Reference Labs Urine Drug Testing Service Product Portfolio
  30. 8.5.5 Genesis Reference Labs Recent Developments
  31. 8.6 Concentra
  32. 8.6.1 Concentra Company Information
  33. 8.6.2 Concentra Business Overview
  34. 8.6.3 Concentra Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Concentra Urine Drug Testing Service Product Portfolio
  36. 8.6.5 Concentra Recent Developments
  37. 8.7 DISA
  38. 8.7.1 DISA Company Information
  39. 8.7.2 DISA Business Overview
  40. 8.7.3 DISA Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 DISA Urine Drug Testing Service Product Portfolio
  42. 8.7.5 DISA Recent Developments
  43. 8.8 Medigold Health
  44. 8.8.1 Medigold Health Company Information
  45. 8.8.2 Medigold Health Business Overview
  46. 8.8.3 Medigold Health Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medigold Health Urine Drug Testing Service Product Portfolio
  48. 8.8.5 Medigold Health Recent Developments
  49. 8.9 Keystone Laboratories
  50. 8.9.1 Keystone Laboratories Company Information
  51. 8.9.2 Keystone Laboratories Business Overview
  52. 8.9.3 Keystone Laboratories Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Keystone Laboratories Urine Drug Testing Service Product Portfolio
  54. 8.9.5 Keystone Laboratories Recent Developments
  55. 8.10 Crystal Health
  56. 8.10.1 Crystal Health Company Information
  57. 8.10.2 Crystal Health Business Overview
  58. 8.10.3 Crystal Health Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Crystal Health Urine Drug Testing Service Product Portfolio
  60. 8.10.5 Crystal Health Recent Developments
  61. 8.11 MedTox
  62. 8.11.1 MedTox Company Information
  63. 8.11.2 MedTox Business Overview
  64. 8.11.3 MedTox Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MedTox Urine Drug Testing Service Product Portfolio
  66. 8.11.5 MedTox Recent Developments
  67. 8.12 Australian Clinical Labs
  68. 8.12.1 Australian Clinical Labs Company Information
  69. 8.12.2 Australian Clinical Labs Business Overview
  70. 8.12.3 Australian Clinical Labs Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Australian Clinical Labs Urine Drug Testing Service Product Portfolio
  72. 8.12.5 Australian Clinical Labs Recent Developments
  73. 8.13 Dominion Diagnostics
  74. 8.13.1 Dominion Diagnostics Company Information
  75. 8.13.2 Dominion Diagnostics Business Overview
  76. 8.13.3 Dominion Diagnostics Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dominion Diagnostics Urine Drug Testing Service Product Portfolio
  78. 8.13.5 Dominion Diagnostics Recent Developments
  79. 8.14 Matrix Diagnostics
  80. 8.14.1 Matrix Diagnostics Company Information
  81. 8.14.2 Matrix Diagnostics Business Overview
  82. 8.14.3 Matrix Diagnostics Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Matrix Diagnostics Urine Drug Testing Service Product Portfolio
  84. 8.14.5 Matrix Diagnostics Recent Developments
  85. 8.15 Dorevitch Pathology
  86. 8.15.1 Dorevitch Pathology Company Information
  87. 8.15.2 Dorevitch Pathology Business Overview
  88. 8.15.3 Dorevitch Pathology Urine Drug Testing Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dorevitch Pathology Urine Drug Testing Service Product Portfolio
  90. 8.15.5 Dorevitch Pathology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst